Skip to main content
63°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
76.72
+0.82 (+1.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
49
50
Next >
Gilead Sciences's Options: A Look at What the Big Money is Thinking
November 15, 2023
Via
Benzinga
Arcellx, A Top 2% Stock, Breaks Out After Inking A $285 Million Deal With Gilead
November 15, 2023
The companies will work together on treatments for multiple myeloma and lymphomas.
Via
Investor's Business Daily
Kite and Arcellx Announce Expansion in Strategic Partnership
November 15, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review
November 10, 2023
The major indexes ended long win streaks. Datadog led earnings winners.
Via
Investor's Business Daily
A Closer Look at Gilead Sciences's Options Market Dynamics
November 09, 2023
Via
Benzinga
Where Gilead Sciences Stands With Analysts
November 09, 2023
Via
Benzinga
Global Anal Cancer Market Size Expected to Reach $1.24 Billion In 2028 as Treatments Advance
November 09, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:BMY),(NASDAQ:GILD),(NYSE:MRK),(NYSE:PFE) EQNX::TICKER_END
Via
FinancialNewsMedia
Buying the dip in high-yield Gilead Sciences
November 09, 2023
Pharma stock Gilead Sciences is well-positioned for the next few years with a growing core business, a healthy pipeline, and cash flow to sustain capital return
Via
MarketBeat
Exposures
COVID-19
Gilead Sciences to Present at Upcoming Investor Conferences
November 08, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today
November 06, 2023
Via
Benzinga
This Is What Whales Are Betting On Gilead Sciences
November 02, 2023
Via
Benzinga
Gilead Sciences Tops Q3 Earnings And Revenue Estimates
November 07, 2023
While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
Via
Talk Markets
Gilead Sciences (GILD) Q3 2023 Earnings Call Transcript
November 07, 2023
GILD earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Gilead Sciences Stock Slides After Hours On Q3 Report - Here's Why
November 07, 2023
Gilead Sciences, Inc. (NASDAQ: GILD) shares are volatile in Tuesday's after-hours session on the heels of the company's
Via
Benzinga
Gilead Sciences Announces Third Quarter 2023 Financial Results
November 07, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Squashes Expectations On The Back Of A Bullish Move For Its Cancer Drugs
November 07, 2023
The biotech company makes three notable treatments for cancer.
Via
Investor's Business Daily
Comparative Study: Gilead Sciences And Industry Competitors In Biotechnology Industry
October 20, 2023
Via
Benzinga
Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity
November 07, 2023
Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemotherapy showed encouraging overall response rate (ORR) and six-month...
Via
Benzinga
S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto
November 07, 2023
Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-cap earnings reports gain momentum.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers
November 06, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and...
Via
Benzinga
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023
November 03, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023
November 02, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Leidos Sees Robust Demand In Digital Modernization, Raises Annual Outlook
October 31, 2023
Leidos Holdings, Inc (NYSE: LDOS) reported third-quarter FY23 revenue growth of 9% year-over-year to $3.92 billion, beating the consensus of $3.77 billion.
Via
Benzinga
Kite and Epic Bio Announce Collaboration to Develop New Therapies for Cancer
October 31, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
3 Pharma Stocks That Are Screaming Buys in October
October 26, 2023
Each company delivers an above-average dividend and revenue growth.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 24, 2023
Via
Benzinga
Gilead Named Number One Overall Philanthropic Funder of HIV-Related Programs for Second Year in a Row by Funders Concerned About AIDS
October 24, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
7 Healthcare Stocks to invest in for a Healthy Future
October 20, 2023
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.
Via
InvestorPlace
New Data Presented at EACS 2023 Further Demonstrate Strong Clinical Profile of Twice-Yearly Sunlenca® for Adults With Multi-Drug Resistant HIV
October 20, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
49
50
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.